近日，雍禾医疗（2279.HK）发布了2024年年报，报告显示，公司全年实现营业收入18.04亿元，同比增长1.5%。值得注意的是，公司在2024年净利润亏损2.26亿元，尽管较2023年的亏损5.46亿元收窄了，但连续的亏损依然给公司的财务状况带来了沉重压力。来源：雍禾医疗2024年年报与此同时，雍禾医疗股价更是跌跌不休。当前已经从上市之初的18.907港元/股，一路跌至2025年4月17日的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.